share_log

Genius Group | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Genius Group | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Genius Group | F-1/A:证券登记表(修正)
美股SEC公告 ·  08/15 10:22
Moomoo AI 已提取核心信息
Genius Group Limited (GNS) has announced the immediate exercise of certain outstanding Series 2024-C warrants to purchase up to 10,950,451 of the company's ordinary shares at a price of $0.35 per share. The exercise is expected to generate approximately $3.8 million in gross proceeds for the company, before deducting placement agent fees and estimated offering expenses. In exchange for the immediate cash exercise of the warrants, Genius Group will issue new unregistered Series 2024-D and Series 2024-E warrants to purchase up to 10,950,451 ordinary shares each. The Series 2024-D warrants will have a term of five and a half years, and the Series 2024-E warrants will have a term of two years from the issuance date. Additionally, the company has agreed to amend...Show More
Genius Group Limited (GNS) has announced the immediate exercise of certain outstanding Series 2024-C warrants to purchase up to 10,950,451 of the company's ordinary shares at a price of $0.35 per share. The exercise is expected to generate approximately $3.8 million in gross proceeds for the company, before deducting placement agent fees and estimated offering expenses. In exchange for the immediate cash exercise of the warrants, Genius Group will issue new unregistered Series 2024-D and Series 2024-E warrants to purchase up to 10,950,451 ordinary shares each. The Series 2024-D warrants will have a term of five and a half years, and the Series 2024-E warrants will have a term of two years from the issuance date. Additionally, the company has agreed to amend existing warrants issued in April 2024, reducing the exercise price to $0.35 per share and issuing an additional 6,000,000 warrants to the holder. The offering closed on May 22, 2024, and the company intends to use the net proceeds for general corporate purposes, including working capital, operating expenses, debt repayment, and support for acquired assets. The shares underlying the warrants are registered under an effective registration statement on Form F-1. The company has not disclosed any plans to list the new warrants on any national securities exchange or other trading system.
Genius Group Limited(GNS)宣布立即行使某些未行使的2024-C系列认股权,以35美分/股的价格购买公司最多10,950,451股普通股。预计该行使将为公司带来约380万美元的总收益,扣除认购代理费和估计的发行费用。作为认股权的即时现金行使,Genius Group将发行新的未注册的2024-D系列和2024-E系列认股权,每个系列最多可购买10,950,451股普通股。2024-D认股权的期限为五年半,2024-E认股权的期限为发行日起两年。此外,公司已同意修改在2024年4月发行的现有认股权,将行使价格降至每股0.35美分,并向持有人发行额外的6,000,000认股权。发行于2024年5月22日,公司打算将净收益用于一般企业用途,包括营运资金、营业费用、债务偿还和支持已收购资产。认股权下的股票已在Form F-1的有效注册声明下注册。公司没有披露任何计划在任何国家证券交易所或其他交易系统上上市新认股权。
Genius Group Limited(GNS)宣布立即行使某些未行使的2024-C系列认股权,以35美分/股的价格购买公司最多10,950,451股普通股。预计该行使将为公司带来约380万美元的总收益,扣除认购代理费和估计的发行费用。作为认股权的即时现金行使,Genius Group将发行新的未注册的2024-D系列和2024-E系列认股权,每个系列最多可购买10,950,451股普通股。2024-D认股权的期限为五年半,2024-E认股权的期限为发行日起两年。此外,公司已同意修改在2024年4月发行的现有认股权,将行使价格降至每股0.35美分,并向持有人发行额外的6,000,000认股权。发行于2024年5月22日,公司打算将净收益用于一般企业用途,包括营运资金、营业费用、债务偿还和支持已收购资产。认股权下的股票已在Form F-1的有效注册声明下注册。公司没有披露任何计划在任何国家证券交易所或其他交易系统上上市新认股权。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息